Medrx News

Medrx: Notice regarding the recording of non-operating expenses

Nov 8 01:30 ET

Medrx: Notice regarding the monthly exercise status of the 29th Stock Acquisition Rights (with exercise price amendment clause) issued by third party allotment

Oct 31 19:50 ET

Medrx: Notice of commencement of MRX-7MLL clinical trials

Oct 28 02:00 ET

Medrx: Notice regarding the monthly exercise status of the 29th Stock Acquisition Rights (with exercise price amendment clause) issued by third party allotment

Sep 30 19:50 ET

Medrx: Notice Concerning Mass Exercise of the 29th Stock Acquisition Rights (with Exercise Price Amendment Clauses) Issued by Third Party Allotment

Sep 24 03:00 ET

Medrx: Notice regarding the Reiwa 6th SME Overseas Expansion Support Project Cost Subsidy (Overseas Application Support Project) Indirect Subsidy Grant Decision

Sep 24 02:00 ET

Medrx: Notice of Patent Assessment (Japan) relating to MRX-4TZT

Sep 5 04:00 ET

Medrx: Notice regarding the monthly exercise status of the 29th Stock Acquisition Rights (with exercise price amendment clause) issued by third party allotment

Sep 1 19:50 ET

Medrx: Announcement of the massive exercise of the 29th subscription rights (with an exercise price adjustment clause) issued by third-party allotment.

Aug 19 03:00 ET

Medrx: Announcement of the massive exercise of the 29th subscription rights (with an exercise price adjustment clause) issued by third-party allotment.

Aug 14 03:00 ET

Medrx: Announcements of individual stocks regarding the recognition of non-operating income, non-operating expenses and special profits

Aug 9 02:00 ET

Medrx: Announcements of individual stocks regarding the monthly exercise status of the 29th subscription rights (with exercise price adjustment clause) issued through a third-party allocation.

Jul 31 19:50 ET

Medrx: Announcement of the massive exercise of the 29th subscription rights (with an exercise price adjustment clause) issued by third-party allotment.

Jul 31 03:00 ET

Medrx: Announcements of individual stocks regarding the decision to provide indirect subsidies for the overseas application support business subsidy program for SMEs and others in overseas expansion support project expenses for fiscal 2024.

Jul 16 02:00 ET

Medrx: Regarding the policy towards reapplying for MRX-5LBT

Jul 15 19:30 ET

Medrx: Announcements of individual stocks: Notification of completion report received for MRX-5LBT review.

Jul 11 19:30 ET

Medrx: Announcement of the massive exercise of the 29th subscription rights (with an exercise price adjustment clause) issued by third-party allotment.

Jul 1 03:00 ET

Medrx: Announcements of individual stocks regarding the monthly exercise status of the 29th subscription rights (with exercise price adjustment clause) issued through a third-party allocation.

Jun 30 19:50 ET

Medrx: Announcements of individual stocks: Notice of the start of the Alto-101 Phase II clinical trial.

Jun 20 19:50 ET

Medrx: Notice regarding the monthly exercise status of the 29th Stock Acquisition Rights (with exercise price amendment clause) issued by third party allotment

Jun 2 19:50 ET